Introduction
============

Metastasis is one of the hallmarks of cancer cells and involves a series of complex processes of cancer cells. These processes include the acquisition of motility, local invasion and entrance into the systemic blood circulation, survival in circulation, and subsequent extravasation and growth at distant organs [@B1]. Additionally, extracellular protease secretion and degradation of the extracellular matrix (ECM) play an important role in cancer invasion. Among these proteases, matrix metalloproteinase (MMP)-2, MMP-9, and urokinase-type plasminogen activator (u-PA) play the most important roles in tumor cell invasion and metastasis.

Chemoprevention is the single or combined use of natural or synthetic agents to prevent, delay, reverse, or reduce the tumorigenic process. This therapy is a promising area of current cancer research. *C. cassia* is a common food spice and presents medicinal properties, such as antiviral [@B2], antioxidant [@B3], and anti-tumorigenic [@B4] activities. Earlier reports have indicated that *C. cassia* primarily contains vital oils and other derivatives, such as cinnamaldehyde, cinnamic acid, cinnamyl alcohol, cinnamate and coumarin [@B5]-[@B7]. *C. cassia* essential oil could inhibit cell proliferation and induce apoptosis in human oral cancer HSC-3 cells [@B4]. However, the effect of *C. cassia* on the metastasis and invasion of lung cancer cells and the underlying mechanisms of such effect remain unclear. In this study, we proposed that *C. cassia* may affect lung adenocarcinoma cells to exert anti-cancer effects. Metastasis is caused by numerous factors. Thus, additional experiments were designed to clarify the detailed mechanism of *C. cassia* in inhibiting the invasion and migration of lung cancer cells.

Material and Methods
====================

Preparation of *C. cassia* extract (CCE)
----------------------------------------

*C. cassia* was purchased from a store in Taichung, Taiwan, and CCE was prepared as previously described [@B8]. Air-dried branches (100 g) were boiled at 70 °C for 24 h with 500 mL of 50% ethanol. Then, the solvent was removed, and the filtrate was lyophilized and stored at -20 °C. The recovery ratio of CCE is 17.25%.

Cell culture
------------

A549 (human lung adenocarcinoma cell line), H1299 (human lung adenocarcinoma cell line), WI-38 (human lung fibroblast cell line), and MRC-5 (normal human fetal lung fibroblast) cell lines were obtained from American Type Culture Collection (Manassas, VA) and cultured in Dulbecco\'s Modified Eagle\'s medium (DMEM; for A549 and H1299) or Basal Medium Eagle (BME; for MRC-5 and WI-38) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin. All cell cultures were maintained at 37 °C in a humidified atmosphere of 5% CO~2~.

Wound healing assay
-------------------

We determined whether CCE could alter the migration of A549 and H1299 cells. We plated 1.0×10^4^ A549 or H1299 cells in six-well plates for 24 h. The cells were wounded by scratching with a pipette tip, then incubated with DMEM containing 0.5% FBS, and treated with different concentrations of CCE for 0, 24, and 48 h. Cells were photographed using a phase-contrast microscope (×100) as described elsewhere [@B9], [@B10].

Microculture tetrazolium (MTT) assay
------------------------------------

Cells were seeded onto 24-well plates at a density of 3×10^4^ cells/well and treated with CCE at a concentration of 0-60 μg/mL at 37℃ for 24 and 48 h. After the exposure period, media were removed and cells were washed with phosphate-buffered saline followed by incubation with 0.5 mg/mL MTT in culture medium for an additional 4 h. The blue formazan crystals of viable cells were dissolved and measured spectrophotometrically at 570 nm [@B11].

Boyden chamber cell invasion and motility assays
------------------------------------------------

After pre-treatment with CCE for 24 h, the cells were harvested and seeded to the Boyden chamber (Neuro Probe, Cabin John, MD) at 1.5×10^4^ cells/well in serum-free medium and then incubated for another 24 h at 37 °C. For the invasion assay, 10 µL of Matrigel (0.5 mg/mL) was applied to polycarbonate membrane filters (8 µm pore size), with the bottom chamber of the apparatus containing standard medium (10% FBS DMEM medium). The invaded cells were fixed with methanol and stained with Giemsa. Cell numbers were counted using a light microscope, whereas motility assay was performed as described for the invasion assay, without Matrigel coating [@B12].

Cell-matrix adhesion assay
--------------------------

After treatment with CCE for 24 h, the cells were placed on 24-well dishes coated with collagen type I or gelatin (10 μL/mL). The cells were washed by phosphate-buffered saline to remove nonadherent cells. After staining with 0.1% crystal violet, fixed cells were lysed in 0.2% Triton X-100, and the absorbance was measured at 550 nm [@B12].

Determination of MMPs and u-PA by zymography
--------------------------------------------

Cells were treated with CCE (0, 20, 40, and 60 μg/mL) for 24 and 48 h. After indicated treatments, the conditioned media were collected, centrifuged to remove any cellular contaminants and stored at -80℃ until use. Collected media were prepared with sodium dodecyl sulphate (SDS) sample buffer without boiling or reduction and subjected to gelatin zymography and casein zymography analysis to determine the MMPs and u-PA, respectively. For gelatin zymography, collected media were subjected to 0.1% gelatin-8% SDS polyacrylamide gel electrophoresis to determine the MMPs. The gels were washed with 2.5% Triton X-100 after electrophoresis and then incubated in the reaction buffer. The gel was then stained with Coomassie brilliant blue R-250, and u-PA activity was visualized by casein zymography [@B9], [@B10], [@B13]. 2% w/v casein and 20 μg/mL plasminogen were added to 8% SDS-PAGE gels. u-PA activity of cells treated or untreated with CCE was measured as described in the gelatin zymography.

Western blot analysis
---------------------

After treatment with different concentrations of CCE for 24 h, the total cell lysates were prepared as described elsewhere [@B11]. The total cell lysates were incubated with the p-FAK, total-FAK, p-ERK1/2, total-ERK1/2, PI3K and RhoA primary antibodies (Cell Singling Technology, Inc., Danvers, MA, USA), washed, and monitored by immunoblot assays using specific secondary antibodies. The relative photographic densities were quantified by scanning the photographic negatives using a gel documentation and analysis system (Alpha-Imager 2000, Alpha Innotech Corporation, San Leandro, CA, USA). After measuring the intensity of each band by densitometry, relative intensities were calculated by normalizing to GAPDH from the corresponding sample.

Statistical analysis
--------------------

Statistical significances were analyzed by one-way ANOVA with post hoc Dunnett\'s test. P value \< 0.05 was considered statistically significant (Sigma-Stat 2.0, Jandel Scientific, San Rafael, CA).

Results
=======

CCE treatment of up to 60 μg/mL for 24 h has no cytotoxic effect on A549 and H1299 cells
----------------------------------------------------------------------------------------

Viability of A549 and H1299 cells after 24 h of CCE treatment (10, 20, and 60 μg/mL) was not significantly different with that of control (0 μg/mL), whereas 48 h of 60 μg/mL CCE treatment resulted in a decline in cell viability of H1299 cells (Figures [1](#F1){ref-type="fig"}A and [1](#F1){ref-type="fig"}B). Thus, 24 h of CCE treatment up to 60 μg/mL had no cytotoxic effect on A549 and H1299 cells. We used this concentration range for 24 h of CCE treatment in all subsequent experiments to investigate the anti-invasive property of CCE. Using the same procedures, we found that this compound did not exert any significant cytotoxicity on nonmalignant human fetal lung fibroblast MRC-5 (Figure [1](#F1){ref-type="fig"}C) and nonmalignant human lung fibroblast cell line WI-38 (Figure [1](#F1){ref-type="fig"}D).

CCE inhibits A549 and H1299 cell migration
------------------------------------------

CCE (up to 60 μg/mL) significantly attenuated cell migration dose-dependently in A549 (Figure [1](#F1){ref-type="fig"}E) and H1299 (Figure [1](#F1){ref-type="fig"}F) cells in the wound healing assay.

CCE inhibits A549 and H1299 cells invasiveness and motility
-----------------------------------------------------------

Whether CCE also suppressed human lung adenocarcinoma A549 and H1299 cellular motility potential and invasive activity was also determined by conducting Boyden chamber invasion and motility assays. Both modified Boyden chamber with or without Matrigel assays showed that CCE significantly inhibited the invasive (Figures [2](#F2){ref-type="fig"}A and [2](#F2){ref-type="fig"}B) activity and motility potential of A549 and H1299 cells dose-dependently (Figures [2](#F2){ref-type="fig"}C and [2](#F2){ref-type="fig"}D). Therefore, CCE could be considered to decrease the metastatic activity of A549 and H1299 cells.

CCE inhibits MMP-2 and u-PA of A549 and H1299 cells
---------------------------------------------------

The results from the gelatin zymography show that CCE inhibited the MMP-2 level for 24 and 48 h in A549 and H1299 cells, respectively (Figures [3](#F3){ref-type="fig"}A and [3](#F3){ref-type="fig"}B). In addition to MMP-2, CCE inhibited the expression of the upper stream u-PA for 24 and 48 h in both cells (Figures [3](#F3){ref-type="fig"}C and [3](#F3){ref-type="fig"}D).

CCE reduces cell-matrix adhesion to gelatin and collagen in A549 and H1299 cells
--------------------------------------------------------------------------------

We also assessed whether CCE regulated cell adhesion to extracellular matrix components. Cells were pre-treated with different concentrations (0, 20, 40, and 60 μg/mL) of CCE prior to the adhesion assay on gelatin (heat-denatured collagen, α~5~β~3~-ligand) and collagen type 1 (α~2~β~1~-ligand). CCE impaired cell adhesion to gelatin (Figures [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B) and collagen type 1(Figures [4](#F4){ref-type="fig"}C and [4](#F4){ref-type="fig"}D) in both cell lines.

CCE decreases FAK and ERK1/2 phosphorylation of A549 cells
----------------------------------------------------------

Western blot analysis was performed to investigate the molecular mechanisms. Compared with the control group, CCE significantly reduced p-FAK Tyr397 and p-FAK Tyr925 expression, but had no effect on t-FAK expression (Figure [4](#F4){ref-type="fig"}E). These results indicated that p-FAK and p-ERK1/2 could mediate the anti-metastasis mechanism of CCE in A549 cells. The signaling transduction proteins ERK1/2 were investigated to confirm whether the expression of FAK downstream was altered. Consequently, expression of phosphorylated ERK1/2 were markedly reduced by CCE in A549 cells, while total protein expression of ERK1/2 was unchanged (Figure [5](#F5){ref-type="fig"}A). These results suggested the involvement of FAK and ERK1/2 signaling pathways in the role of CCE on A549 cells.

CCE inhibits RhoA protein expression of A549 cell
-------------------------------------------------

In-depth investigation of the molecular mechanisms revealed that CCE reduced the expression of RhoA but had no obvious influence on the expression of PI3K in A549 cells (Figure [5](#F5){ref-type="fig"}B). These results suggest that RhoA may have crucial roles in CCE inhibition of A549 cells motility, migration, and invasion.

In summary, these findings suggested that CCE could inhibit the invasion and migration via downregulation of the phosphorylation of ERK1/2 and FAK and activities of MMP-2 and u-PA in human lung A549 and H1299 cells (Figure [6](#F6){ref-type="fig"}).

Discussion
==========

Metastasis of lung cancer is the most important cause of patient death, and various treatments have targeted the prevention of metastasis. This study investigated the anti-cancer effects of CCE on lung cancer. We provided clear evidence that CCE, at concentrations without cytotoxicity (up to 60 μg/mL for 24 h), suppressed tumor cell migratory, motility, and invasiveness potential in A549 and H1299 cells. Tumor cell invasion requires cell invasion and digestion of the basement membrane and the extracellular matrix by MMPs and u-PA [@B14]-[@B16]. Thus, we hypothesized that CCE could affect one of these mechanisms in lung adenocarcinoma cells. CCE suppressed the u-PA and MMP-2 activities in both cell lines.

FAK is a focal adhesion-associated protein tyrosine kinase, and the activated p-FAK stimulates the signaling transduction pathway and modulates cancer cell proliferation, survival, motility, adhesion, migration, and invasion [@B17], [@B18]. In the present study, we demonstrated that CCE downregulated phosphorylation of FAK and ERK1/2 in A549 cells, which are essential molecules in MMP production to regulate the degradation of ECM and enhance cell invasion [@B19], [@B20]. These results indicated that p-FAK could mediate the anti-metastasis mechanism of CCE via the ERK1/2 and FAK pathways in A549 cells. RhoA can promote cell proliferation, invasion, and metastasis in some tumors [@B21]. Interestingly, we observed the downregulation of the RhoA protein expression by CCE in A549 cells, targeting the actin cytoskeleton to further exert anti-metastatic properties.

Chemotherapy has benefits, but the systemic toxicity and side-effects can be traumatic to patient. Thus, the reduction in anticancer drugs-caused systemic toxicity has been a major challenge in maximizing the beneficial outcome of this therapy for cancer. Phytotherapeutic agents with high anti-tumor effect and less toxicity to normal tissues have been suggested as possible candidates for their capability to improve the efficacy of chemotherapeutic agents [@B22]. In this study, CCE has anti-invasion and anti-migration effects of highly metastatic human lung carcinoma cells, while CCE exerts no cytotoxicity of normal human lung cell lines as a combination medication with adjuvant chemotherapy on human lung cancer patients.

In conclusion, CCE inhibited the phosphorylation of ERK1/2 and FAK and also downregulated MMP-2 and u-PA to inhibit the metastasis of human lung A549 and H1299 cells. The results confirm the hypothesis that CCE possesses anti-cancer properties on lung adenocarcinoma cells, elucidating the mechanism responsible for these effects. This study may also facilitate the identification of a novel therapeutic agent for human lung adenocarcinoma.
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![Effects of CCE on cell viability and wound healing assay in human lung cancer A549 and H1299 cells. (A) A549 (B) H1299 (C) MRC-5 and (D) WI-38 cells were treated with different concentrations (0, 20, 40, and 60 μg/mL) of CCE for 24 and 48 h prior to MTT assay for cell viability. The wound healing assay was conducted as described in the Materials and Methods section after (E) A549 and (F) H1299 cells were treated with different concentrations (0, 20, 40, and 60 μg/mL) of CCE for 24 and 48 h. micrograph: 40×. Scale bar, 50 μm. Results were statistically evaluated using one-way ANOVA with post hoc Dunnett\'s test (\*\*, *P*\<0.01; \*\*\*, *P*\<0.001). Results from three repeated and separate experiments were similar.](ijmsv15p0115g001){#F1}

![Effects of CCE on the cell motility and invasion assays in human lung cancer A549 and H1299 cells. Cell invasion (A and B) and motility (C and D) assays in A549 cells and H1299 cells were measured after the cells were treated with different concentrations (0, 20, 40, and 60 μg/mL) of CCE for 24 h. micrograph: 100×. Scale bar, 100 μm. Data represent mean ± SD, with that of control as 100%. Statistical significance of the results was analyzed using one-way ANOVA with post hoc Dunnett\'s test (\*, *P*\<0.05; \*\*, *P*\<0.01; \*\*\*, *P*\<0.001).](ijmsv15p0115g002){#F2}

![Effects of CCE on MMP-2 and u-PA in human lung cancer A549 and H1299 cells. Activities of MMP-2 were measured by gelatin zymography after the (A) A549 and (B) H1299 cells were treated with different concentrations (0, 20, 40, and 60 μg/mL) of CCE for 24 and 48 h in. (C) A549 and (D) H1299 cells were treated with CCE for 24 and 48 h and then subjected to casein zymography to analyze the activities of u-PA, as described in Materials and Methods. Data represented mean ± SD, with that of control as 100%. Statistical significance of results was analyzed using one-way ANOVA with post hoc Dunnett\'s test (\*, *P*\<0.05; \*\*, *P*\<0.01; \*\*\*, *P*\<0.001).](ijmsv15p0115g003){#F3}

![Effects of CCE on cell-matrix adhesion in the human lung cancer cells. The adhesion on (A and B) gelatin and (C and D) collagen type 1 of A549 and H1299 cells was assayed after the cells were treated with different concentration (0, 20, 40, and 60 μg/mL) of CCE for 24 h. Similar results were obtained from three repeated and independent experiments using one-way ANOVA with post hoc Dunnett\'s test (\*, *P*\<0.05; \*\*, *P*\<0.01).](ijmsv15p0115g004){#F4}

![Effects of CCE on the expression of FAK and ERK1/2 in the human lung cancer cells. Expression levels of (A) FAK, ERK, (B) PI3K, and RhoA and their phosphorylation after CCE treatments of A549 cells were measured by Western blot analysis, with GAPDH as the internal control. Similar results were obtained from three repeated and independent experiments using one-way ANOVA with post hoc Dunnett\'s test (\*, P\<0.05; \*\*, P\<0.01).](ijmsv15p0115g005){#F5}

![Proposed molecular targets in anti-invasiveness and anti-migration efficacy of CCE in lung cancer cells.](ijmsv15p0115g006){#F6}
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